Evidence map›Paper›PMID 33732369›Full record

ArticleOncology letters2021

Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B-cell lymphoma 2.

Jun An, Jieping Yang, Yang Yao, Kaining Lu, Zhiqiang Zhao, Meng Yu, Yuyan Zhu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Roles of SIRT6 in kidney disease: a novel therapeutic target.Cellular and molecular life sciences : CMLS · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Jun AnDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Jieping YangDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Yang YaoDepartment of Physiology, Shenyang Medical College, Shenyang, Liaoning 110034, P.R. China.
Kaining LuDepartment of Urology and Nephrology, Ningbo First Hospital, The Affiliated Hospital of Zhejiang University, Ningbo, Zhejiang 315010, P.R. China.
Zhiqiang ZhaoDepartment of Intensive Care Unit, Mudanjiang Forestry Center Hospital, Mudanjiang, Heilongjiang 157000, P.R. China.
Meng YuKey Laboratory of Transgenic Animal Research, Department of Laboratory Animal Science, China Medical University, Shenyang, Liaoning 110122, P.R. China.
Yuyan ZhuDepartment of Urology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
First Hospital of China Medical University · CNChina Medical University · CNMudanjiang Medical University · CNNingbo First Hospital · CNShenyang Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sirtuin 6 (

Indexed as

B-cell lymphoma 2clear cell renal cell carcinomametastasisproliferationsirtuin 6

Identifiers

PMID33732369
PMCPMC7905630
OpenAlexW3131238710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.